Anuh Pharma Ltd.

Financial

	Anuh Pharma	Wanbury	Ind-Swift Lab.
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	0.0	n/a	2.9 %
Financials
5 yr Average ROE	15.87 %	-30.56 %	9.6 %
5yr average Equity Multiplier	1.62	-3.1	2.49
5yr Average Asset Turnover Ratio	1.35	1.51	0.67
5yr Avg Net Profit Margin	7.23 %	7.58 %	6.7 %
Price to Book	2.7	14.71	0.73
P/E	19.06	20.29	3.7
5yr Avg Cash Conversion Cycle	42.81 Days	-119.82 Days	76.78 Days
Inventory Days	50.87 Days	20.62 Days	126.74 Days
Days Receivable	111.12 Days	49.78 Days	95.44 Days
Days Payable	117.6 Days	205.91 Days	94.9 Days
5yr Average Interest Coverage Ratio	48.66	2.36	3.49
5yr Avg ROCE	21.17 %	-51.74 %	12.63 %
5yr Avg Operating Profit Margin	10.21 %	4.22 %	19.31 %
5 yr average Debt to Equity	0.02	-0.61	1.22
5yr CAGR Net Profit	10.73 %	-2.79 %	n/a
5yr Average Return on Assets	9.84 %	11.1 %	7.66 %
Shareholdings
Promoter Holding	69.92 %	39.63 %	40.94 %
Share Pledged by Promoters	0.0	76.74 %	0.0
Change in Promoter Holding (3 Yrs)	-0.67 %	-0.22 %	-1.06 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Anuh Pharma	Wanbury	Ind-Swift Lab.
Product Wise Break-Up	Product Wise Break-Up Bulk drug and Chemicals 100.0 API`s & Formulation 0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceuticals 0 Bulk drug and Chemicals 0 API`s & Formulation 0 Others 100	Product Wise Break-Up Pharmaceutical 100.0 Bulk drug and Chemicals 0 API`s & Formulation 0
Location Wise Break-Up	Location Wise Break-Up India 45.02 Rest of the World 0 Others 54.98	Location Wise Break-Up Rest of the World 0 India 30.27 Others 69.73	Location Wise Break-Up Rest of the World 0 India 27.72 Others 72.28
Brand Wise Break-Up	Brand Wise Break-Up Erythromycin 33.38 Cortico Steroids 15.41 Higher Macrolides 14.5 Sulphadoxine 13.6 Pyrazinamide 5.74 Chloramhenicol 4.98 Gliclazide 4.23 Ambroxol HCL 3.02 Others 5.14	-	-